JPS4892400A - - Google Patents

Info

Publication number
JPS4892400A
JPS4892400A JP48018463A JP1846373A JPS4892400A JP S4892400 A JPS4892400 A JP S4892400A JP 48018463 A JP48018463 A JP 48018463A JP 1846373 A JP1846373 A JP 1846373A JP S4892400 A JPS4892400 A JP S4892400A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48018463A
Other languages
Japanese (ja)
Other versions
JPS5516434B2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4892400A publication Critical patent/JPS4892400A/ja
Publication of JPS5516434B2 publication Critical patent/JPS5516434B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP1846373A 1972-02-23 1973-02-16 Expired JPS5516434B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00228743A US3833591A (en) 1972-02-23 1972-02-23 1,3,4,5-tetrahydropyrrolo(4,3,2-d,e)isoquinolines and related compounds

Publications (2)

Publication Number Publication Date
JPS4892400A true JPS4892400A (en) 1973-11-30
JPS5516434B2 JPS5516434B2 (en) 1980-05-01

Family

ID=22858420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1846373A Expired JPS5516434B2 (en) 1972-02-23 1973-02-16

Country Status (6)

Country Link
US (1) US3833591A (en)
JP (1) JPS5516434B2 (en)
BE (1) BE795451A (en)
DE (1) DE2306605A1 (en)
FR (1) FR2181738B1 (en)
GB (1) GB1418354A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003502426A (en) * 1999-06-17 2003-01-21 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Indoloazepines as vasopressin receptor antagonists

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978066A (en) * 1973-11-06 1976-08-31 Ayerst, Mckenna And Harrison Ltd. Certain 4,6-dihydropyrrolotriazoline-quinoline derivatives
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
US3900477A (en) * 1973-11-06 1975-08-19 Ayerst Mckenna & Harrison 5-amino-and 5-hydrazinodihydropyrroloisoquinoline derivatives
US4029672A (en) * 1976-02-26 1977-06-14 American Hoechst Corporation Aminoalkylpyrrolobenzoxazalkanes
JPS5729817U (en) * 1980-07-26 1982-02-17
US4545935A (en) * 1983-09-12 1985-10-08 Iowa State University Research Foundation, Inc. Amidoalkylation reactions of anilines
DE3525564A1 (en) * 1985-07-15 1987-02-05 Schering Ag TRICYCLIC COMPOUNDS WITH INDOLSTRUCTURE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
CA1320486C (en) * 1988-06-01 1993-07-20 John J. Lafferty .alpha. -adrenergic receptor antagonists
EP0344982B1 (en) * 1988-06-01 1994-11-23 Smithkline Beecham Corporation Alpha-adrenergic receptor antagonists
US4959360A (en) * 1988-06-01 1990-09-25 Smithkline Beecham Corporation α-adrenergic receptor antagonists
US4978660A (en) * 1988-06-01 1990-12-18 Smithkline Beecham Corporation α-adrenergic receptor antagonists
EP0344979B1 (en) * 1988-06-01 1994-11-09 Smithkline Beecham Corporation Alfa-adrenergic receptor antagonists
CA1320954C (en) * 1988-06-01 1993-08-03 Smithkline Beckman Corporation .alpha.-adrenergic receptor antagonists
US5006521A (en) * 1988-06-01 1991-04-09 Smithkline Beecham Corporation α-adrenergic receptor antagonists and methods of use thereas
US4963547A (en) * 1988-06-01 1990-10-16 Smithkline Beecham Corporation Alpha-andrenergic receptor antagonists and use thereas
US4981848A (en) * 1989-02-23 1991-01-01 Smithkline Beecham Corporation Alpha-adrenergic receptor antagonists
US4981849A (en) * 1989-02-23 1991-01-01 Smithkline Beecham Corporation Alpha-adrenergic receptor antagonists
CA2679346A1 (en) * 2007-03-13 2008-09-18 Biovitrum Ab (Publ) Tricyclic isoquinoline derivatives for treatment of obesity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182071A (en) * 1961-06-27 1965-05-04 Warner Lambert Pharmaceutical Acylated indole derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003502426A (en) * 1999-06-17 2003-01-21 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Indoloazepines as vasopressin receptor antagonists

Also Published As

Publication number Publication date
US3833591A (en) 1974-09-03
FR2181738B1 (en) 1976-03-05
GB1418354A (en) 1975-12-17
JPS5516434B2 (en) 1980-05-01
FR2181738A1 (en) 1973-12-07
BE795451A (en) 1973-08-16
DE2306605A1 (en) 1973-09-06

Similar Documents

Publication Publication Date Title
JPS5627370B2 (en)
FR2181738B1 (en)
JPS5214822B2 (en)
FR2182588A1 (en)
CH566074A5 (en)
CH567033A5 (en)
CH586165A5 (en)
CH1028673A4 (en)
CH581076A5 (en)
CH591435A5 (en)
CH1444873A4 (en)
CH209674A4 (en)
CH524573A4 (en)
CH554555A (en)
CH561134A5 (en)
CH563243A5 (en)
CH591527A5 (en)
CH563862A5 (en)
CH563920A5 (en)
CH565273A (en)
CH566011A5 (en)
BG17145A1 (en)
CH566613A5 (en)
CH566910A5 (en)
CH566913A5 (en)